We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.18B
AUM Growth
-$113M
Cap. Flow
-$283M
Cap. Flow %
-12.95%
Top 10 Hldgs %
39.24%
Holding
318
New
18
Increased
122
Reduced
118
Closed
20
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARKG icon
301
ARK Genomic Revolution ETF
ARKG
$1.55B
-3,007
Closed -$225K
BIZD icon
302
VanEck BDC Income ETF
BIZD
$1.59B
-18,772
Closed -$322K
CRWD icon
303
CrowdStrike
CRWD
$194B
-48,780
Closed -$3M
DELL icon
304
Dell
DELL
$262B
-5,870
Closed -$310K
ESGE icon
305
iShares ESG Aware MSCI EM ETF
ESGE
$6.58B
-15,730
Closed -$652K
FPE icon
306
First Trust Preferred Securities and Income ETF
FPE
$6.32B
-5,963,209
Closed -$122M
FXB icon
307
Invesco CurrencyShares British Pound Sterling Trust
FXB
$77.8M
-1,550
Closed -$201K
GBDC icon
308
Golub Capital BDC
GBDC
$3.34B
-10,489
Closed -$166K
GLW icon
309
Corning
GLW
$119B
-5,559
Closed -$203K
MRNA icon
310
Moderna
MRNA
$21.8B
-572
Closed -$220K
PFFA icon
311
Virtus InfraCap US Preferred Stock ETF
PFFA
$2.45B
-12,991
Closed -$323K
PTON icon
312
Peloton Interactive
PTON
$2.77B
-3,507
Closed -$305K
FLNA
313
Filana Therapeutics
FLNA
$48.8M
-4,692
Closed -$291K
VCSH icon
314
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
-2,973
Closed -$245K
VO icon
315
Vanguard Morningstar Mid-Cap ETF
VO
$106B
-3,856
Closed -$228K
ALBO
316
DELISTED
Albireo Pharma Inc
ALBO
-8,242
Closed -$257K
CALA
317
DELISTED
Calithera Biosciences, Inc
CALA
-5,754
Closed -$251K
SOLY
318
DELISTED
Soliton, Inc.
SOLY
-54,643
Closed -$1.11M

Similar funds

Grimes & Company's Q4 2021 Portfolio in Review

As of Q4 2021, Grimes & Company held 318 positions worth $2.18B, down 4.9% from $2.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Grimes & Company withdrew a net $283M in Q4 2021, closing 20 positions and reducing 118 holdings. Its most notable exit was First Trust Preferred Securities and Income ETF, an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Grimes & Company opened a new position in JPMorgan Ultra-Short Income ETF worth $2.58M.

  • Grimes & Company's largest Q4 2021 buy was JPMorgan Ultra-Short Income ETF: 51,110 shares worth $2.58M.
  • Grimes & Company added most to State Street Technology Select Sector SPDR ETF in Q4 2021, an estimated $10.9M increase.
  • Grimes & Company's biggest Q4 2021 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $51.5M.
  • Grimes & Company fully exited First Trust Preferred Securities and Income ETF in Q4 2021, selling an estimated $122M.
  • Grimes & Company's ten largest holdings make up 39% of its $2.18B portfolio in Q4 2021.
  • Grimes & Company opened 18 new positions and closed 20 in Q4 2021.
  • Grimes & Company's portfolio value fell 4.9% quarter-over-quarter to $2.18B.

Based on Grimes & Company's 13F filing for Q4 2021, filed 1 Feb 2022.